The May 28, 2019 edition of Chronicle on WCVB 5 featured our incredible Memory and Aging Program participants and a look at how we’re working together to win the battle against Alzheimer’s by finding effective treatments and prevention. See their inspiring stories and why there’s hope on the horizon in the clips below.
If you’re 40+ with normal memory or mild memory loss, you can help us in this fight. Here’s how: butler.org/ALZregistry
Chronicle’s Anthony Everett takes us inside Butler Hospital, one of the top Alzheimer’s research centers in the world.
A genetic test revealed that Dave Kalberer carried the markers for Alzheimer’s. He is now enrolled in a clinical trial through the Memory and Aging Program at Butler Hospital.
Anthony Everett reports on a billion-dollar effort underway to find breakthrough treatments in the next decade.
Alzheimer’s disease is a relentless force, stealing patients’ dignity and emotionally exhausting their families, caregivers and friends. How do we fight back?
Louisa Thompson, Ph.D., research scientist at Brown University and Butler Hospital, will evaluate how app-based and online cognitive tests might be used to detect subtle changes in memory and thinking associated with Alzheimer’s.
Butler Hospital was one of 27 sites across the U.S. to study the drug flortaucipir through a partnership between its Memory and Aging Program and Rhode Island Hospital.
Siena Restaurants co-owner Chef Anthony Tarro shares why his father’s experience with Alzheimer’s disease, and how he and his family continue to fight back against the disease in his name, even after his passing.
There may soon be a new tool available to more firmly diagnose Alzheimer’s disease, according to the results of a study recently published in JAMA Neurology and conducted in part at the Memory and Aging Program at Butler Hospital.
Susan Sullivan approaches her volunteer work for the Memory and Aging Program at Butler Hospital from a unique perspective: she’s been a caregiver to those with Alzheimer’s for nearly 50 years.
Dr. Daniel Gibbs is on a mission to change attitudes on Alzheimer’s after 13 years living with the disease himself. Here’s the important reason why…
New Data for Investigational Drug for Early-Onset Alzheimer’s Illustrates Value of “Failed” Research Studies
Initial results in a clinical trial aimed at early-onset Alzheimer’s didn’t look promising – but upon further review, the data has spurred further study.
How this neuropsychologist has come full circle and full-steam ahead in his career and his quest to help end Alzheimer’s at the Memory and Aging Program at Butler Hospital.
Watch this Alzheimer’s educational video to learn about prevention, symptoms, treatment, resources and research from a panel of Rhode Island experts.